Skip to Content

Newsletter No. 62 -- April 2003

ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:

CIP Web Site:  http://www.cancer.gov/bip

Meeting Announcements:

  1. APRIL 24-25 NIH REGIONAL SEMINAR IN PALO ALTO, CALIFORNIA (NOT-OD-03-023)
    URL: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-03-023.html
  2. INTERNATIONAL SOCIETY OF MAGNETIC RESONANCE IN MEDICINE, TORONTO, May 10-16, 2003
    URL: http://www.ismrm.org/03/
  3. SOCIETY OF NUCLEAR MEDICINE, JUNE 21-25, 2003, NEW ORLEANS, LA.
    URL: http://www.snm.org

NIH

  1. IMPACT OF THE HIPAA PRIVACY RULE ON NIH PROCESSES INVOLVING THE REVIEW, FUNDING, AND PROGRESS MONITORING OF GRANTS, COOPERATIVE AGREEMENTS AND RESEARCH CONTRACTS (NOT-OD-03-025)
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html
  2. FINAL NIH STATEMENT ON SHARING RESEARCH DATA (NOT-OD-03-032)
    Starting with the October 1, 2003 receipt date, investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why data sharing is not possible.
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html
  3. PUBLICATION OF "FINANCIAL CONFLICT OF INTEREST - OBJECTIVITY IN RESEARCH: INSTITUTIONAL POLICY REVIEW" (NOT-OD-03-026)
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-026.html
  4. SALARY LIMITATION ON GRANTS, COOPERATIVE AGREEMENTS, AND CONTRACTS (NOT-OD-03-034)
    URL: http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-03-034.html
  5. REMINDER TO APPLICANTS ABOUT REQUIREMENT TO SUBMIT COMPLETE AND UP-TO-DATE OTHER SUPPORT INFORMATION (NOT-OD-03-029)
    NIH requires submission of complete and up-to-date "other support" information before an award can be made.
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-029.html
  6. RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARD (NRSA) STIPEND INCREASE AND OTHER BUDGETARY CHANGES EFFECTIVE FOR FISCAL YEAR 2003 (NOT-OD-03-033)
    The budgetary changes described below for Fiscal Year 2003 Kirschstein-NRSA awards affect the stipend levels for predoctoral and postdoctoral trainees and fellows. Only predoctoral and postdoctoral stipends are increased this fiscal year. It should be noted that the described budgetary changes are effective only for Kirschstein-NRSA awards made with FY 2003 funds.
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-033.html AND http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-03-036.html
  7. EXTENSION OF BISTI PROGRAM ANNOUNCEMENTS (PA-00-117, PA-00-118) (NOT-OD-03-031)
    The participating Institutes and Centers announce extensions of the following program announcements for one additional deadline, March 27, 2003:
  8. RAPID ACCESS TO NCI DISCOVERY RESOURCES (RAND) (NOT-CA-03-009)
    Receipt Dates: April 1, October 1;
    LOI Receipt: 1 month earlier
    The National Cancer Institute is requesting applications for the following initiative: Rapid Access to NCI Discovery Resources (RAND) program. The RAND program will make available to academic investigators, on a competitive basis, the discovery, and early preclinical development contract resources of NCI's Developmental Therapeutics Program.
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-03-009.html
  9. TECHNOLOGY DEVELOPMENT FOR BIOMEDICAL APPLICATIONS (NCRR, NHGRI, NIBIB, NIEHS) (PAR-03-075)
    APPLICATION RECEIPT DATES: June 1, and October 1, 2003
    The purpose of this program announcement (PA) is to invite innovative applications for (1) the development of new and improved instruments or devices, (2) the development of new methodologies using existing instruments, or (3) the development of software related to instrumentation. This PA will use the NIH R21 and R21/R33 award mechanism(s).
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-03-075.html
  10. INSTITUTIONAL CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM (NCI) (PAR-03-083)
    The National Cancer Institute (NCI) Institutional Clinical Oncology Career Development Program is intended to train clinical researchers whose career focus will be on patient-oriented therapeutic research and not on laboratory-based research. To achieve the purpose of this Program, awards are made to institutions for up to five years for the development and implementation of training programs providing clinicians with all of the necessary information and training that will enable them to design, implement and manage all phases of therapeutic cancer clinical trials research. This PA will use the NIH Mentored Clinical Scientist Development Program Award or K12 mechanism.
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-03-083.html
  11. NEUROIMAGING THE EFFECTS OF DRUGS OF ABUSE ON THE DEVELOPMENT OF THE HUMAN NERVOUS SYSTEM (NIDA) (RFA-DA-04-002)
    LETTER OF INTENT RECEIPT DATE: May 19, 2003
    APPLICATION RECEIPT DATE: June 18, 2003
    The purpose of this RFA is to support studies that take advantage of the rapidly evolving methodology of neuroimaging to further our understanding of the consequences of drug exposure, abuse and addiction on the developing human brain. This RFA will use the NIH R01 award mechanism. NIDA intends to commit approximately $3 million in FY 2004 to fund 8 to 10 new and/or competitive continuation grants in response to this RFA.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-04-002.html
  12. RUTH L. KIRSCHSTEIN NATIONAL RESEARCH SERVICE AWARDS FOR INDIVIDUAL POSTDOCTORAL FELLOWS (F32) (PA-03-067)
    The National Institutes of Health (NIH) awards individual postdoctoral fellowships (F32) to promising applicants with the potential to become productive, independent investigators in fields related to the mission of the NIH constituent institutes and centers.
    URL: http://grants.nih.gov/grants/guide/pa-files/PA-03-067.html
  13. INDIVIDUAL BIOMEDICAL INFORMATICS FELLOWSHIPS (NLM) (PAR-03-070)
    Individual biomedical informatics fellowships provide support for the training of informatics scientists able to perform research into basic informatics problems or to application of informatics to any area of biomedicine, including clinical medicine, basic biomedical research, clinical and health services research, public health, professional education, and administration. Post-doctoral, pre-doctoral and, in certain specified fields, some post-baccalaureate candidates are eligible.
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-03-070.html

Other Government Agencies

  1. NSF BIOMEDICAL ENGINEERING PROGRAM AND RESEARCH TO AID PERSONS WITH DISABILITIES PROGRAM (BME/RAPD) (NSF 03-560)
    Deadlines:
    September 01, 2003 - October 15, 2003 Proposals (except for Biophotonics) will be accepted annually between September 1 and October 15. There are no deadlines for Undergraduate Design Project proposals.
    December 15, 2003 - February 01, 2004 Proposals for Biophotonics will be accepted annually between December 15 and February 1 of the following year.
    Research in bioengineering, with diagnosis or treatment-related goals, that applies engineering principals to problems in biology and medicine while advancing engineering knowledge is eligible for support. Areas of research interest include: Biophotonics; Biomedical sensing and imaging systems and others.
    URL: http://www.nsf.gov/pubs/2003/nsf03560/nsf03560.pdf
  2. FY04 NUCLEAR ENERGY PROTOCOL FOR RESEARCH ISOTOPES (NEPRI)
    The U.S Department of Energy's NEPRI is an annual process to determine the radionuclides needed by the research community. The goal of NEPRI is to generate a list of research nuclides that DOE will consider producing in FY04 (starting Oct. 1, 2003). The Department asks that researchers complete a NEPRI Pre-Order Form, providing information about what radionuclides are needed. This is a peer-reviewed process. The completed form must be returned no later than close of business June 27, 2003. Failure to do so may mean your nuclide will not be produced in FY 2004.
    URL: http://www.ornl.gov/isotopes/nepri2004.html

___________________________________

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507